Global Biologics CDMO Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Biologics CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biologics CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biologics CDMO market in any manner.
Global Biologics CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lonza Group AG
Samsung Biologics
AbbVie
WuXi Biologics
Toyobo
AGC
Thermo Fisher Scientific
ICON Plc
Boehringer Ingelheim
Fujifilm Diosynth Biotechnologies
Market Segmentation (by Type)
Biological Agent
Biosimilar Drug
Market Segmentation (by Application)
Cell Therapy
Drug Development
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biologics CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Biologics CDMO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Biologics CDMO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Biologics CDMO market in any manner.
Global Biologics CDMO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lonza Group AG
Samsung Biologics
AbbVie
WuXi Biologics
Toyobo
AGC
Thermo Fisher Scientific
ICON Plc
Boehringer Ingelheim
Fujifilm Diosynth Biotechnologies
Market Segmentation (by Type)
Biological Agent
Biosimilar Drug
Market Segmentation (by Application)
Cell Therapy
Drug Development
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Biologics CDMO Market
- Overview of the regional outlook of the Biologics CDMO Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Biologics CDMO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Biologics CDMO
1.2 Key Market Segments
1.2.1 Biologics CDMO Segment by Type
1.2.2 Biologics CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOLOGICS CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biologics CDMO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biologics CDMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOLOGICS CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Global Biologics CDMO Sales by Manufacturers (2019-2024)
3.2 Global Biologics CDMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Biologics CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biologics CDMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biologics CDMO Sales Sites, Area Served, Product Type
3.6 Biologics CDMO Market Competitive Situation and Trends
3.6.1 Biologics CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biologics CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOLOGICS CDMO INDUSTRY CHAIN ANALYSIS
4.1 Biologics CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOLOGICS CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOLOGICS CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biologics CDMO Sales Market Share by Type (2019-2024)
6.3 Global Biologics CDMO Market Size Market Share by Type (2019-2024)
6.4 Global Biologics CDMO Price by Type (2019-2024)
7 BIOLOGICS CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biologics CDMO Market Sales by Application (2019-2024)
7.3 Global Biologics CDMO Market Size (M USD) by Application (2019-2024)
7.4 Global Biologics CDMO Sales Growth Rate by Application (2019-2024)
8 BIOLOGICS CDMO MARKET SEGMENTATION BY REGION
8.1 Global Biologics CDMO Sales by Region
8.1.1 Global Biologics CDMO Sales by Region
8.1.2 Global Biologics CDMO Sales Market Share by Region
8.2 North America
8.2.1 North America Biologics CDMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biologics CDMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biologics CDMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biologics CDMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biologics CDMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Lonza Group AG
9.1.1 Lonza Group AG Biologics CDMO Basic Information
9.1.2 Lonza Group AG Biologics CDMO Product Overview
9.1.3 Lonza Group AG Biologics CDMO Product Market Performance
9.1.4 Lonza Group AG Business Overview
9.1.5 Lonza Group AG Biologics CDMO SWOT Analysis
9.1.6 Lonza Group AG Recent Developments
9.2 Samsung Biologics
9.2.1 Samsung Biologics Biologics CDMO Basic Information
9.2.2 Samsung Biologics Biologics CDMO Product Overview
9.2.3 Samsung Biologics Biologics CDMO Product Market Performance
9.2.4 Samsung Biologics Business Overview
9.2.5 Samsung Biologics Biologics CDMO SWOT Analysis
9.2.6 Samsung Biologics Recent Developments
9.3 AbbVie
9.3.1 AbbVie Biologics CDMO Basic Information
9.3.2 AbbVie Biologics CDMO Product Overview
9.3.3 AbbVie Biologics CDMO Product Market Performance
9.3.4 AbbVie Biologics CDMO SWOT Analysis
9.3.5 AbbVie Business Overview
9.3.6 AbbVie Recent Developments
9.4 WuXi Biologics
9.4.1 WuXi Biologics Biologics CDMO Basic Information
9.4.2 WuXi Biologics Biologics CDMO Product Overview
9.4.3 WuXi Biologics Biologics CDMO Product Market Performance
9.4.4 WuXi Biologics Business Overview
9.4.5 WuXi Biologics Recent Developments
9.5 Toyobo
9.5.1 Toyobo Biologics CDMO Basic Information
9.5.2 Toyobo Biologics CDMO Product Overview
9.5.3 Toyobo Biologics CDMO Product Market Performance
9.5.4 Toyobo Business Overview
9.5.5 Toyobo Recent Developments
9.6 AGC
9.6.1 AGC Biologics CDMO Basic Information
9.6.2 AGC Biologics CDMO Product Overview
9.6.3 AGC Biologics CDMO Product Market Performance
9.6.4 AGC Business Overview
9.6.5 AGC Recent Developments
9.7 Thermo Fisher Scientific
9.7.1 Thermo Fisher Scientific Biologics CDMO Basic Information
9.7.2 Thermo Fisher Scientific Biologics CDMO Product Overview
9.7.3 Thermo Fisher Scientific Biologics CDMO Product Market Performance
9.7.4 Thermo Fisher Scientific Business Overview
9.7.5 Thermo Fisher Scientific Recent Developments
9.8 ICON Plc
9.8.1 ICON Plc Biologics CDMO Basic Information
9.8.2 ICON Plc Biologics CDMO Product Overview
9.8.3 ICON Plc Biologics CDMO Product Market Performance
9.8.4 ICON Plc Business Overview
9.8.5 ICON Plc Recent Developments
9.9 Boehringer Ingelheim
9.9.1 Boehringer Ingelheim Biologics CDMO Basic Information
9.9.2 Boehringer Ingelheim Biologics CDMO Product Overview
9.9.3 Boehringer Ingelheim Biologics CDMO Product Market Performance
9.9.4 Boehringer Ingelheim Business Overview
9.9.5 Boehringer Ingelheim Recent Developments
9.10 Fujifilm Diosynth Biotechnologies
9.10.1 Fujifilm Diosynth Biotechnologies Biologics CDMO Basic Information
9.10.2 Fujifilm Diosynth Biotechnologies Biologics CDMO Product Overview
9.10.3 Fujifilm Diosynth Biotechnologies Biologics CDMO Product Market Performance
9.10.4 Fujifilm Diosynth Biotechnologies Business Overview
9.10.5 Fujifilm Diosynth Biotechnologies Recent Developments
10 BIOLOGICS CDMO MARKET FORECAST BY REGION
10.1 Global Biologics CDMO Market Size Forecast
10.2 Global Biologics CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biologics CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Biologics CDMO Market Size Forecast by Region
10.2.4 South America Biologics CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biologics CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Biologics CDMO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biologics CDMO by Type (2025-2030)
11.1.2 Global Biologics CDMO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biologics CDMO by Type (2025-2030)
11.2 Global Biologics CDMO Market Forecast by Application (2025-2030)
11.2.1 Global Biologics CDMO Sales (Kilotons) Forecast by Application
11.2.2 Global Biologics CDMO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Biologics CDMO
1.2 Key Market Segments
1.2.1 Biologics CDMO Segment by Type
1.2.2 Biologics CDMO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BIOLOGICS CDMO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Biologics CDMO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Biologics CDMO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BIOLOGICS CDMO MARKET COMPETITIVE LANDSCAPE
3.1 Global Biologics CDMO Sales by Manufacturers (2019-2024)
3.2 Global Biologics CDMO Revenue Market Share by Manufacturers (2019-2024)
3.3 Biologics CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Biologics CDMO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Biologics CDMO Sales Sites, Area Served, Product Type
3.6 Biologics CDMO Market Competitive Situation and Trends
3.6.1 Biologics CDMO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Biologics CDMO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 BIOLOGICS CDMO INDUSTRY CHAIN ANALYSIS
4.1 Biologics CDMO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BIOLOGICS CDMO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 BIOLOGICS CDMO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Biologics CDMO Sales Market Share by Type (2019-2024)
6.3 Global Biologics CDMO Market Size Market Share by Type (2019-2024)
6.4 Global Biologics CDMO Price by Type (2019-2024)
7 BIOLOGICS CDMO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Biologics CDMO Market Sales by Application (2019-2024)
7.3 Global Biologics CDMO Market Size (M USD) by Application (2019-2024)
7.4 Global Biologics CDMO Sales Growth Rate by Application (2019-2024)
8 BIOLOGICS CDMO MARKET SEGMENTATION BY REGION
8.1 Global Biologics CDMO Sales by Region
8.1.1 Global Biologics CDMO Sales by Region
8.1.2 Global Biologics CDMO Sales Market Share by Region
8.2 North America
8.2.1 North America Biologics CDMO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Biologics CDMO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Biologics CDMO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Biologics CDMO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Biologics CDMO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Lonza Group AG
9.1.1 Lonza Group AG Biologics CDMO Basic Information
9.1.2 Lonza Group AG Biologics CDMO Product Overview
9.1.3 Lonza Group AG Biologics CDMO Product Market Performance
9.1.4 Lonza Group AG Business Overview
9.1.5 Lonza Group AG Biologics CDMO SWOT Analysis
9.1.6 Lonza Group AG Recent Developments
9.2 Samsung Biologics
9.2.1 Samsung Biologics Biologics CDMO Basic Information
9.2.2 Samsung Biologics Biologics CDMO Product Overview
9.2.3 Samsung Biologics Biologics CDMO Product Market Performance
9.2.4 Samsung Biologics Business Overview
9.2.5 Samsung Biologics Biologics CDMO SWOT Analysis
9.2.6 Samsung Biologics Recent Developments
9.3 AbbVie
9.3.1 AbbVie Biologics CDMO Basic Information
9.3.2 AbbVie Biologics CDMO Product Overview
9.3.3 AbbVie Biologics CDMO Product Market Performance
9.3.4 AbbVie Biologics CDMO SWOT Analysis
9.3.5 AbbVie Business Overview
9.3.6 AbbVie Recent Developments
9.4 WuXi Biologics
9.4.1 WuXi Biologics Biologics CDMO Basic Information
9.4.2 WuXi Biologics Biologics CDMO Product Overview
9.4.3 WuXi Biologics Biologics CDMO Product Market Performance
9.4.4 WuXi Biologics Business Overview
9.4.5 WuXi Biologics Recent Developments
9.5 Toyobo
9.5.1 Toyobo Biologics CDMO Basic Information
9.5.2 Toyobo Biologics CDMO Product Overview
9.5.3 Toyobo Biologics CDMO Product Market Performance
9.5.4 Toyobo Business Overview
9.5.5 Toyobo Recent Developments
9.6 AGC
9.6.1 AGC Biologics CDMO Basic Information
9.6.2 AGC Biologics CDMO Product Overview
9.6.3 AGC Biologics CDMO Product Market Performance
9.6.4 AGC Business Overview
9.6.5 AGC Recent Developments
9.7 Thermo Fisher Scientific
9.7.1 Thermo Fisher Scientific Biologics CDMO Basic Information
9.7.2 Thermo Fisher Scientific Biologics CDMO Product Overview
9.7.3 Thermo Fisher Scientific Biologics CDMO Product Market Performance
9.7.4 Thermo Fisher Scientific Business Overview
9.7.5 Thermo Fisher Scientific Recent Developments
9.8 ICON Plc
9.8.1 ICON Plc Biologics CDMO Basic Information
9.8.2 ICON Plc Biologics CDMO Product Overview
9.8.3 ICON Plc Biologics CDMO Product Market Performance
9.8.4 ICON Plc Business Overview
9.8.5 ICON Plc Recent Developments
9.9 Boehringer Ingelheim
9.9.1 Boehringer Ingelheim Biologics CDMO Basic Information
9.9.2 Boehringer Ingelheim Biologics CDMO Product Overview
9.9.3 Boehringer Ingelheim Biologics CDMO Product Market Performance
9.9.4 Boehringer Ingelheim Business Overview
9.9.5 Boehringer Ingelheim Recent Developments
9.10 Fujifilm Diosynth Biotechnologies
9.10.1 Fujifilm Diosynth Biotechnologies Biologics CDMO Basic Information
9.10.2 Fujifilm Diosynth Biotechnologies Biologics CDMO Product Overview
9.10.3 Fujifilm Diosynth Biotechnologies Biologics CDMO Product Market Performance
9.10.4 Fujifilm Diosynth Biotechnologies Business Overview
9.10.5 Fujifilm Diosynth Biotechnologies Recent Developments
10 BIOLOGICS CDMO MARKET FORECAST BY REGION
10.1 Global Biologics CDMO Market Size Forecast
10.2 Global Biologics CDMO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Biologics CDMO Market Size Forecast by Country
10.2.3 Asia Pacific Biologics CDMO Market Size Forecast by Region
10.2.4 South America Biologics CDMO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Biologics CDMO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Biologics CDMO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Biologics CDMO by Type (2025-2030)
11.1.2 Global Biologics CDMO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Biologics CDMO by Type (2025-2030)
11.2 Global Biologics CDMO Market Forecast by Application (2025-2030)
11.2.1 Global Biologics CDMO Sales (Kilotons) Forecast by Application
11.2.2 Global Biologics CDMO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biologics CDMO Market Size Comparison by Region (M USD)
Table 5. Global Biologics CDMO Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Biologics CDMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biologics CDMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biologics CDMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics CDMO as of 2022)
Table 10. Global Market Biologics CDMO Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biologics CDMO Sales Sites and Area Served
Table 12. Manufacturers Biologics CDMO Product Type
Table 13. Global Biologics CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biologics CDMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biologics CDMO Market Challenges
Table 22. Global Biologics CDMO Sales by Type (Kilotons)
Table 23. Global Biologics CDMO Market Size by Type (M USD)
Table 24. Global Biologics CDMO Sales (Kilotons) by Type (2019-2024)
Table 25. Global Biologics CDMO Sales Market Share by Type (2019-2024)
Table 26. Global Biologics CDMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Biologics CDMO Market Size Share by Type (2019-2024)
Table 28. Global Biologics CDMO Price (USD/Ton) by Type (2019-2024)
Table 29. Global Biologics CDMO Sales (Kilotons) by Application
Table 30. Global Biologics CDMO Market Size by Application
Table 31. Global Biologics CDMO Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Biologics CDMO Sales Market Share by Application (2019-2024)
Table 33. Global Biologics CDMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Biologics CDMO Market Share by Application (2019-2024)
Table 35. Global Biologics CDMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Biologics CDMO Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Biologics CDMO Sales Market Share by Region (2019-2024)
Table 38. North America Biologics CDMO Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Biologics CDMO Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Biologics CDMO Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Biologics CDMO Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Biologics CDMO Sales by Region (2019-2024) & (Kilotons)
Table 43. Lonza Group AG Biologics CDMO Basic Information
Table 44. Lonza Group AG Biologics CDMO Product Overview
Table 45. Lonza Group AG Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Lonza Group AG Business Overview
Table 47. Lonza Group AG Biologics CDMO SWOT Analysis
Table 48. Lonza Group AG Recent Developments
Table 49. Samsung Biologics Biologics CDMO Basic Information
Table 50. Samsung Biologics Biologics CDMO Product Overview
Table 51. Samsung Biologics Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Samsung Biologics Business Overview
Table 53. Samsung Biologics Biologics CDMO SWOT Analysis
Table 54. Samsung Biologics Recent Developments
Table 55. AbbVie Biologics CDMO Basic Information
Table 56. AbbVie Biologics CDMO Product Overview
Table 57. AbbVie Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. AbbVie Biologics CDMO SWOT Analysis
Table 59. AbbVie Business Overview
Table 60. AbbVie Recent Developments
Table 61. WuXi Biologics Biologics CDMO Basic Information
Table 62. WuXi Biologics Biologics CDMO Product Overview
Table 63. WuXi Biologics Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. WuXi Biologics Business Overview
Table 65. WuXi Biologics Recent Developments
Table 66. Toyobo Biologics CDMO Basic Information
Table 67. Toyobo Biologics CDMO Product Overview
Table 68. Toyobo Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Toyobo Business Overview
Table 70. Toyobo Recent Developments
Table 71. AGC Biologics CDMO Basic Information
Table 72. AGC Biologics CDMO Product Overview
Table 73. AGC Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. AGC Business Overview
Table 75. AGC Recent Developments
Table 76. Thermo Fisher Scientific Biologics CDMO Basic Information
Table 77. Thermo Fisher Scientific Biologics CDMO Product Overview
Table 78. Thermo Fisher Scientific Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Thermo Fisher Scientific Business Overview
Table 80. Thermo Fisher Scientific Recent Developments
Table 81. ICON Plc Biologics CDMO Basic Information
Table 82. ICON Plc Biologics CDMO Product Overview
Table 83. ICON Plc Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. ICON Plc Business Overview
Table 85. ICON Plc Recent Developments
Table 86. Boehringer Ingelheim Biologics CDMO Basic Information
Table 87. Boehringer Ingelheim Biologics CDMO Product Overview
Table 88. Boehringer Ingelheim Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Boehringer Ingelheim Business Overview
Table 90. Boehringer Ingelheim Recent Developments
Table 91. Fujifilm Diosynth Biotechnologies Biologics CDMO Basic Information
Table 92. Fujifilm Diosynth Biotechnologies Biologics CDMO Product Overview
Table 93. Fujifilm Diosynth Biotechnologies Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Fujifilm Diosynth Biotechnologies Business Overview
Table 95. Fujifilm Diosynth Biotechnologies Recent Developments
Table 96. Global Biologics CDMO Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Biologics CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Biologics CDMO Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Biologics CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Biologics CDMO Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Biologics CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Biologics CDMO Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Biologics CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Biologics CDMO Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Biologics CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Biologics CDMO Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Biologics CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Biologics CDMO Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Biologics CDMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Biologics CDMO Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Biologics CDMO Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Biologics CDMO Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Biologics CDMO Market Size Comparison by Region (M USD)
Table 5. Global Biologics CDMO Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Biologics CDMO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Biologics CDMO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Biologics CDMO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologics CDMO as of 2022)
Table 10. Global Market Biologics CDMO Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Biologics CDMO Sales Sites and Area Served
Table 12. Manufacturers Biologics CDMO Product Type
Table 13. Global Biologics CDMO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Biologics CDMO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Biologics CDMO Market Challenges
Table 22. Global Biologics CDMO Sales by Type (Kilotons)
Table 23. Global Biologics CDMO Market Size by Type (M USD)
Table 24. Global Biologics CDMO Sales (Kilotons) by Type (2019-2024)
Table 25. Global Biologics CDMO Sales Market Share by Type (2019-2024)
Table 26. Global Biologics CDMO Market Size (M USD) by Type (2019-2024)
Table 27. Global Biologics CDMO Market Size Share by Type (2019-2024)
Table 28. Global Biologics CDMO Price (USD/Ton) by Type (2019-2024)
Table 29. Global Biologics CDMO Sales (Kilotons) by Application
Table 30. Global Biologics CDMO Market Size by Application
Table 31. Global Biologics CDMO Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Biologics CDMO Sales Market Share by Application (2019-2024)
Table 33. Global Biologics CDMO Sales by Application (2019-2024) & (M USD)
Table 34. Global Biologics CDMO Market Share by Application (2019-2024)
Table 35. Global Biologics CDMO Sales Growth Rate by Application (2019-2024)
Table 36. Global Biologics CDMO Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Biologics CDMO Sales Market Share by Region (2019-2024)
Table 38. North America Biologics CDMO Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Biologics CDMO Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Biologics CDMO Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Biologics CDMO Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Biologics CDMO Sales by Region (2019-2024) & (Kilotons)
Table 43. Lonza Group AG Biologics CDMO Basic Information
Table 44. Lonza Group AG Biologics CDMO Product Overview
Table 45. Lonza Group AG Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Lonza Group AG Business Overview
Table 47. Lonza Group AG Biologics CDMO SWOT Analysis
Table 48. Lonza Group AG Recent Developments
Table 49. Samsung Biologics Biologics CDMO Basic Information
Table 50. Samsung Biologics Biologics CDMO Product Overview
Table 51. Samsung Biologics Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Samsung Biologics Business Overview
Table 53. Samsung Biologics Biologics CDMO SWOT Analysis
Table 54. Samsung Biologics Recent Developments
Table 55. AbbVie Biologics CDMO Basic Information
Table 56. AbbVie Biologics CDMO Product Overview
Table 57. AbbVie Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. AbbVie Biologics CDMO SWOT Analysis
Table 59. AbbVie Business Overview
Table 60. AbbVie Recent Developments
Table 61. WuXi Biologics Biologics CDMO Basic Information
Table 62. WuXi Biologics Biologics CDMO Product Overview
Table 63. WuXi Biologics Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. WuXi Biologics Business Overview
Table 65. WuXi Biologics Recent Developments
Table 66. Toyobo Biologics CDMO Basic Information
Table 67. Toyobo Biologics CDMO Product Overview
Table 68. Toyobo Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Toyobo Business Overview
Table 70. Toyobo Recent Developments
Table 71. AGC Biologics CDMO Basic Information
Table 72. AGC Biologics CDMO Product Overview
Table 73. AGC Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. AGC Business Overview
Table 75. AGC Recent Developments
Table 76. Thermo Fisher Scientific Biologics CDMO Basic Information
Table 77. Thermo Fisher Scientific Biologics CDMO Product Overview
Table 78. Thermo Fisher Scientific Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Thermo Fisher Scientific Business Overview
Table 80. Thermo Fisher Scientific Recent Developments
Table 81. ICON Plc Biologics CDMO Basic Information
Table 82. ICON Plc Biologics CDMO Product Overview
Table 83. ICON Plc Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. ICON Plc Business Overview
Table 85. ICON Plc Recent Developments
Table 86. Boehringer Ingelheim Biologics CDMO Basic Information
Table 87. Boehringer Ingelheim Biologics CDMO Product Overview
Table 88. Boehringer Ingelheim Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Boehringer Ingelheim Business Overview
Table 90. Boehringer Ingelheim Recent Developments
Table 91. Fujifilm Diosynth Biotechnologies Biologics CDMO Basic Information
Table 92. Fujifilm Diosynth Biotechnologies Biologics CDMO Product Overview
Table 93. Fujifilm Diosynth Biotechnologies Biologics CDMO Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Fujifilm Diosynth Biotechnologies Business Overview
Table 95. Fujifilm Diosynth Biotechnologies Recent Developments
Table 96. Global Biologics CDMO Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Biologics CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Biologics CDMO Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Biologics CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Biologics CDMO Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Biologics CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Biologics CDMO Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Biologics CDMO Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Biologics CDMO Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Biologics CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Biologics CDMO Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Biologics CDMO Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Biologics CDMO Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Biologics CDMO Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Biologics CDMO Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Biologics CDMO Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Biologics CDMO Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Biologics CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biologics CDMO Market Size (M USD), 2019-2030
Figure 5. Global Biologics CDMO Market Size (M USD) (2019-2030)
Figure 6. Global Biologics CDMO Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biologics CDMO Market Size by Country (M USD)
Figure 11. Biologics CDMO Sales Share by Manufacturers in 2023
Figure 12. Global Biologics CDMO Revenue Share by Manufacturers in 2023
Figure 13. Biologics CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biologics CDMO Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biologics CDMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biologics CDMO Market Share by Type
Figure 18. Sales Market Share of Biologics CDMO by Type (2019-2024)
Figure 19. Sales Market Share of Biologics CDMO by Type in 2023
Figure 20. Market Size Share of Biologics CDMO by Type (2019-2024)
Figure 21. Market Size Market Share of Biologics CDMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biologics CDMO Market Share by Application
Figure 24. Global Biologics CDMO Sales Market Share by Application (2019-2024)
Figure 25. Global Biologics CDMO Sales Market Share by Application in 2023
Figure 26. Global Biologics CDMO Market Share by Application (2019-2024)
Figure 27. Global Biologics CDMO Market Share by Application in 2023
Figure 28. Global Biologics CDMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biologics CDMO Sales Market Share by Region (2019-2024)
Figure 30. North America Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Biologics CDMO Sales Market Share by Country in 2023
Figure 32. U.S. Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Biologics CDMO Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Biologics CDMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Biologics CDMO Sales Market Share by Country in 2023
Figure 37. Germany Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Biologics CDMO Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Biologics CDMO Sales Market Share by Region in 2023
Figure 44. China Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Biologics CDMO Sales and Growth Rate (Kilotons)
Figure 50. South America Biologics CDMO Sales Market Share by Country in 2023
Figure 51. Brazil Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Biologics CDMO Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Biologics CDMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Biologics CDMO Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Biologics CDMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biologics CDMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biologics CDMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Biologics CDMO Sales Forecast by Application (2025-2030)
Figure 66. Global Biologics CDMO Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Biologics CDMO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Biologics CDMO Market Size (M USD), 2019-2030
Figure 5. Global Biologics CDMO Market Size (M USD) (2019-2030)
Figure 6. Global Biologics CDMO Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Biologics CDMO Market Size by Country (M USD)
Figure 11. Biologics CDMO Sales Share by Manufacturers in 2023
Figure 12. Global Biologics CDMO Revenue Share by Manufacturers in 2023
Figure 13. Biologics CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Biologics CDMO Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Biologics CDMO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Biologics CDMO Market Share by Type
Figure 18. Sales Market Share of Biologics CDMO by Type (2019-2024)
Figure 19. Sales Market Share of Biologics CDMO by Type in 2023
Figure 20. Market Size Share of Biologics CDMO by Type (2019-2024)
Figure 21. Market Size Market Share of Biologics CDMO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Biologics CDMO Market Share by Application
Figure 24. Global Biologics CDMO Sales Market Share by Application (2019-2024)
Figure 25. Global Biologics CDMO Sales Market Share by Application in 2023
Figure 26. Global Biologics CDMO Market Share by Application (2019-2024)
Figure 27. Global Biologics CDMO Market Share by Application in 2023
Figure 28. Global Biologics CDMO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Biologics CDMO Sales Market Share by Region (2019-2024)
Figure 30. North America Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Biologics CDMO Sales Market Share by Country in 2023
Figure 32. U.S. Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Biologics CDMO Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Biologics CDMO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Biologics CDMO Sales Market Share by Country in 2023
Figure 37. Germany Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Biologics CDMO Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Biologics CDMO Sales Market Share by Region in 2023
Figure 44. China Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Biologics CDMO Sales and Growth Rate (Kilotons)
Figure 50. South America Biologics CDMO Sales Market Share by Country in 2023
Figure 51. Brazil Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Biologics CDMO Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Biologics CDMO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Biologics CDMO Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Biologics CDMO Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Biologics CDMO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Biologics CDMO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Biologics CDMO Market Share Forecast by Type (2025-2030)
Figure 65. Global Biologics CDMO Sales Forecast by Application (2025-2030)
Figure 66. Global Biologics CDMO Market Share Forecast by Application (2025-2030)
